O
11.80
0.59 (5.26%)
Penutupan Terdahulu | 11.21 |
Buka | 11.18 |
Jumlah Dagangan | 217,579 |
Purata Dagangan (3B) | 268,177 |
Modal Pasaran | 441,797,920 |
Julat 52 Minggu | |
Tarikh Pendapatan | 30 Jul 2025 - 4 Aug 2025 |
Hasil Dividen (DY TTM) | 13.67% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 0.26% |
Nisbah Semasa (MRQ) | 30.03 |
Aliran Tunai Operasi (OCF TTM) | -83.80 M |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Biotechnology (US) | Bercampur | Menurun |
Biotechnology (Global) | Bercampur | Menurun | |
Stok | Oruka Therapeutics, Inc. | Menaik | - |
AISkor Stockmoo
1.0
Konsensus Penganalisis | 1.5 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | -2.0 |
Purata Bergerak Teknikal | 2.5 |
Osilator Teknikal | 2.0 |
Purata | 1.00 |
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis. |
|
Sektor | Healthcare |
Industri | Biotechnology |
% Dimiliki oleh Orang Dalam | 3.25% |
% Dimiliki oleh Institusi | 86.54% |
Julat 52 Minggu | ||
Median | 40.00 (238.98%) | |
Jumlah | 1 Beli |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Wedbush | 15 May 2025 | 40.00 (238.98%) | Beli | 9.46 |
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
01 Jul 2025 | Pengumuman | Oruka Therapeutics Announces Promotion of Laura Sandler to Chief Operating Officer |
21 May 2025 | Pengumuman | Oruka Therapeutics to Present at the Jefferies Global Healthcare Conference |
20 May 2025 | Pengumuman | Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody |
14 May 2025 | Pengumuman | Oruka Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update |
29 Apr 2025 | Pengumuman | Oruka Therapeutics to Present at Bank of America Securities 2025 Health Care Conference |
Hasil Dividen (DY TTM) | 13.67% |
Purata Hasil Dividen 1T | 8.32% |
Jangkaan Pembayaran Dividen Seterusnya | Aug 2025 |
Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
---|---|---|---|
29 Aug 2024 | - | 28 Aug 2024 | 1.613 Tunai |
Hasil Dividen Tahunan
Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
---|---|---|---|
2024 | 1.61 | 1 | 8.32 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |